Holmes Biopharma, Inc.: Omaha Operations Resume

SCOTTSDALE, ARIZONA, May 20 (MARKET WIRE) --
Holmes Biopharma, Inc. (OTCBB: HLMB) announces that its clinic in Omaha
Nebraska has resumed operations with business as usual. This brief
interruption has not affected the ability of the Omaha clinic to carry
out services to clients and study participants.

The Company intends to operate the Omaha clinic at full capacity. "We can
assure our clients and shareholders that we will continue to provide the
highest quality of products and services", stated John F. Metcalfe,
President CEO Holmes Biopharma, Inc.

On behalf of the Board of Directors

John F. Metcalfe President, CEO

Certain statements in this press release constitute "forward looking
statements" within the meaning of the United States Securities
Legislation. The Company's actual results could differ from those in the
forward-looking statements. Do not construe this information as
investment advice. This is not a solicitation to buy or sell securities.
This does not purport to be a complete analysis of the Company. Investing
in securities is speculative and carries a high degree of risk. Past
performance does not guarantee future results. Readers should consult
their own independent advisers with any investment, including any
contemplated investment. All information contained in this press release
should be independently investigated. This press release contains
forward-looking statements. These remarks involve risks and
uncertainties. Risks are not limited to quarterly fluctuations in results
or the companies' management of growth and competition. Other risks are
detailed in the Company's SEC filings. Actual results may differ
materially from such information set forth herein.

Contacts:
Holmes Biopharma, Inc.
John F. Metcalfe
President, CEO
1-800-778-4990
Email: ir@holmesbiopharma.com
Website: www.holmesbiopharma.com

Copyright 2008, Market Wire, All rights reserved.

-0-